Expression of Tumour-Associated MUC1 Is a Poor Prognostic Marker in Breast Cancer in Kumasi, Ghana

BACKGROUND: Immunohistochemical assessment of breast cancer and stratification into the basic molecular subtypes afford a much deeper insight into the biology of breast cancer, while presenting with opportunities to exploit personalized, targeted treatment. Traditionally, the oestrogen, progesterone...

Descripción completa

Detalles Bibliográficos
Autores principales: Atta Manu, E., Bedu-Addo, K., Titiloye, N. A., Ameh-Mensah, C., Opoku, F., Duduyemi, B. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193303/
https://www.ncbi.nlm.nih.gov/pubmed/32377198
http://dx.doi.org/10.1155/2020/9752952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193303/
https://www.ncbi.nlm.nih.gov/pubmed/32377198
http://dx.doi.org/10.1155/2020/9752952

Ejemplares similares